The RealReal, Inc.
NASDAQ:REALLuxury Goods
+$1.13 today
- Market cap
- $1.52B
- Beta
- 2.71
- P/E (TTM)
- -57.3
- EPS (TTM)
- -$0.22
Volume 3.37M
Average 3.37M
REAL Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
The RealReal, Inc.NASDAQ: REAL
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development growth accelerates
Q1 FY2026 research & development of $64.63M rose 10.3% year over year, ahead of the +7.5% change in trailing-twelve-month research & development. Sequentially, it rose 5.8% from the prior quarter.
Context
- Research & development amounted to 35.1% of revenue in FY2025, down 2.9 pp from a year earlier.
- Research & development increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +10.3% holds above the trailing-twelve-month pace of +7.5%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 242.91M USD
- Year-over-year change
- +6.7%
- 4-year CAGR
- +3.4%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 242.91M | +6.7% |
| FY2024 | 2024-12-31 | 227.73M | +1.1% |
| FY2023 | 2023-12-31 | 225.35M | — |
| FY2022 | 2022-12-31 | 0 | -100.0% |
| FY2021 | 2021-12-31 | 212.3M | — |
Research & Development vs competitors
How REAL compares with its peers on the latest reported figures
- REAL's LTM Mar 2026 research & development of $248.93M is the highest of the 11 companies compared; the peer median is $0.
- Research & development amounts to 34.5% of revenue for REAL, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $248.93M | +7.5% | — | 34.5% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Aug 2026 | $0 | — | — | 0.0% | |
| LTM Aug 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Apr 2026 | $0 | — | — | 0.0% | |
| LTM Apr 2026 | $0 | — | — | 0.0% | |
| LTM May 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding REAL) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for REAL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 467.69M | 603.49M | 549.3M | 600.48M | 692.85M |
| Cost of Revenue | 194.22M | 254.8M | 173.03M | 152.96M | 209.03M |
| Gross Profit | 273.48M | 348.69M | 376.28M | 447.52M | 483.82M |
| Gross Margin | 58.5% | 57.8% | 68.5% | 74.5% | 69.8% |
| Research & Development | 212.3M | 0 | 225.35M | 227.73M | 242.91M |
| Selling, General & Admin | 239.17M | 258.33M | 499.11M | 242.99M | 264.84M |
| Operating Expenses | 488.39M | 537.85M | 542.57M | 504.02M | 507.75M |
| Depreciation & Amortization | 42.97M | 27.67M | 31.7M | 33.1M | 33M |
| EBITDA | (171.55M) | (158.13M) | (125.79M) | (79.44M) | 19.27M |
| EBITDA Margin | -36.7% | -26.2% | -22.9% | -13.2% | 2.8% |
| Operating Income | (214.91M) | (189.16M) | (166.29M) | (56.5M) | (23.93M) |
| Operating Margin | -46.0% | -31.3% | -30.3% | -9.4% | -3.5% |
| Interest Income | 365K | 3.19M | 8.81M | 7.94M | 4.26M |
| Interest Expense | 21.53M | 10.47M | 10.7M | 21.38M | 27.7M |
| Other Income / Expenses | (21.14M) | (7.11M) | (1.9M) | (77.43M) | (17.5M) |
| Income Before Tax | (236.05M) | (196.27M) | (168.19M) | (133.93M) | (41.44M) |
| Pre-Tax Margin | -50.5% | -32.5% | -30.6% | -22.3% | -6.0% |
| Income Tax Expense | 56K | 172K | 283K | 276K | 363K |
| Net Income | (236.11M) | (196.45M) | (168.47M) | (134.2M) | (41.8M) |
| Net Margin | -50.5% | -32.6% | -30.7% | -22.3% | -6.0% |
| EPS (Basic) | (2.60) | (2.04) | (1.64) | (1.24) | (0.36) |
| EPS (Diluted) | (2.60) | (2.04) | (1.64) | (1.24) | (0.68) |
| Weighted Avg Shares | 91.41M | 95.92M | 101.81M | 107.88M | 287.18M |
| Weighted Avg Shares (Diluted) | 91.41M | 95.92M | 101.81M | 107.88M | 291.28M |
The RealReal, Inc.
NASDAQ:REAL
Intrinsic Alpha fair value
Locked
Current Price
$12.62
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.